Immunotherapeutic tumor treatment method using an interleukin-2 receptor alpha, beta-selective agonist in combination with adoptive cell transfer therapy
Nektar Therapeutics;The Regents of The University of California
发明人:
Charych, Deborah H.,Ribas, Antoni,Parisi, Giulia
申请号：
AU2018227810
公开号：
AU2018227810A1
申请日:
2018.03.01
申请国别(地区):
AU
年份:
2019
代理人:
摘要：
Provided are methods and compositions directed towards the treatment of an individual having cancer by providing adoptive cell transfer therapy and administering to the individual a long acting IL-2Rαβ-biased agonist.
